# Ad-HGF Treatment for Myocardial Infarction

> **NCT02844283** · PHASE1,PHASE2 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Ad-HGF
- **OTHER:** 0.9% NaCl

## Key facts

- **NCT ID:** NCT02844283
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-07
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02844283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02844283, "Ad-HGF Treatment for Myocardial Infarction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02844283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*